LEVBIO fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Level Bio AB engages in the development, manufacturing, and marketing of instruments for deoxyribonucleic acid analysis. Its products include Clinical diagnostics, Extraction and purification, Biobank, General lab equipment, Next-generation sequencing, PCR, Cloning and Single-cell. The Company was founded in 1998 and is headquartered in Nacka, Sweden.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
LEVBIO has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company